rs766809608
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_000136.3(FANCC):c.1589T>C(p.Leu530Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L530L) has been classified as Likely benign.
Frequency
Consequence
NM_000136.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FANCC | NM_000136.3 | c.1589T>C | p.Leu530Ser | missense_variant | Exon 15 of 15 | ENST00000289081.8 | NP_000127.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152188Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251396 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727196 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:3
This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 530 of the FANCC protein (p.Leu530Ser). This variant is present in population databases (rs766809608, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with FANCC-related conditions. ClinVar contains an entry for this variant (Variation ID: 216284). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FANCC protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Identified in patients with breast cancer or leukemia (PMID: 33471991, 26580448); This variant is associated with the following publications: (PMID: 26580448, Gordon2000[Book], 33471991) -
Fanconi anemia complementation group C Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L530S variant (also known as c.1589T>C), located in coding exon 14 of the FANCC gene, results from a T to C substitution at nucleotide position 1589. The leucine at codon 530 is replaced by serine, an amino acid with dissimilar properties. This variant has been reported in 1/1120 pediatric cancer patients who underwent whole genome sequencing and/or whole exome sequencing; this patient was diagnosed with B-cell acute lymphoblastic leukemia (Zhang J et al. N Engl J Med, 2015 Dec;373:2336-2346). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at